Aflac Inc raised its 2026 Japan pre-tax profit margin range to 35% to 38%, while returning $1.1 billion to shareholders in the third quarter through $804 million of buybacks and $305 million of dividends.
AFL · Aflac Inc
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Aflac Incorporated reported third-quarter net earnings of $303 million, or $.61 per diluted share, down from $1.6 billion, or $3.08 per diluted share, as $1.1 billion of net investment losses outweighed revenue declines.
Aflac Incorporated reported third-quarter net earnings of $303 million, or $0.61 per diluted share, versus $1.6 billion, or $3.08 per diluted share a year ago. Adjusted earnings were $1.2 billion, down 8.5%, and the board declared a $0.61 fourth-quarter dividend.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Aug 7, 2026TL;DR. Aflac reported Q2 adjusted EPS of $1.75 (down 1.7% YoY) but $1.80 ex-FX (up 1.1%), returned $1.3B to shareholders, and raised its Japan reinsurance limit to 30% of FSA reserves while lowering its 2026 U.S. net earned premium growth guidance to just below the 3–6% range and signaling Japan benefit ratio at the high end of 60–63%.
- + Returned $1.3B to shareholders in Q2 via $983M repurchases and $309M dividends, extending the 43-year dividend increase record.
- + Raised Japan reinsurance limit to up to 30% of FSA reserves (from 10% of GAAP assets) to reduce risk and boost ROE.
- + Adjusted EPS ex-FX grew 1.1% YoY to $1.80 and adjusted ROE ex-FX was a solid 16.6%.
- − Lowered 2026 U.S. net earned premium growth guidance to just below the 3–6% range (from low end of range).
- − Now expects full-year 2026 Japan benefit ratio at the high end of 60–63% guidance range due to lapse mix.
- − U.S. benefit ratio rose 220 bps YoY to 49.5% from elevated group disability claims, pressuring U.S. pretax margin to 20.9% (-160 bps).
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted earnings excluding current period foreign currency impact non-GAAP | $910M | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationAdjusted earnings $883M (the result of another reconciliation in this filing)
+$27M Current period foreign currency impact
= Adjusted earnings excluding current period foreign currency impact $910M
|
|||
| Adjusted return on equity - reported non-GAAP | 12.7% | the three months ended June 30, 2026 filing | — |
| Adjusted return on equity excluding foreign currency remeasurement non-GAAP | 16.6% | the three months ended June 30, 2026 filing | — |
| Average weekly producer equivalent (U.S. agents) | 5,100 | the second quarter of 2026 filing | — |
| Pretax adjusted earnings margin (Aflac Japan) non-GAAP | 34.3% | the three months ended June 30, 2026 filing | — |
| 12-Month Rolling Premium Persistency | 92.7% | 2026 YTD | — |
| Adjusted book value excluding foreign currency remeasurement per share non-GAAP | $41.22 | Q2 2026 | — |
| Adjusted book value per share non-GAAP | $55.01 | Q2 2026 | — |
| Adjusted Leverage Ratio non-GAAP | 21.8% | 2Q26 | — |
| Adjusted ROE non-GAAP | 16.6% | 2Q26 | — |
| Aflac Inc. unencumbered liquidity | $3.3B | 2Q26 | — |
| Annualized adjusted return on equity excluding foreign currency remeasurement non-GAAP | 16.6% | Q2 2026 | — |
| Annualized return on average shareholders' equity | 10.9% | Q2 2026 | — |
| Average Weekly Producer Equivalents | 4,982 | Q1 2026 | — |
| Benefit Ratio (Aflac Japan) | 64% | 2Q26 | — |
| Benefit Ratio (Aflac U.S.) | 49.5% | 2Q26 | — |
| Dividends | $309M | 2Q26 | — |
| Expense Ratio (Aflac Japan) | 20.2% | 2Q26 | — |
| Expense Ratio (Aflac U.S.) | 36.1% | 2Q26 | — |
| Pretax adjusted earnings non-GAAP | -$10M | 2Q26 | — |
| Pretax adjusted earnings - Aflac Japan (yen) non-GAAP | ¥118.2B | Q2 2026 | — |
| Pretax adjusted earnings - Aflac U.S. non-GAAP | $370M | Q2 2026 | — |
| Pretax Profit Margin (Aflac Japan) | 34.3% | 2Q26 | — |
| Pretax Profit Margin (Aflac U.S.) | 20.9% | 2Q26 | — |
| Productivity (Production/ Avg. Weekly Producers) | 63,778 | Q1 2026 | — |
| Regulatory ESR | 226% | 2Q26 | — |
| Regulatory ESR with USP | 240% | 2Q26 | — |
| Share Repurchase | $983M | 2Q26 | — |
| Total new annualized premium sales (Aflac Japan) | $123M | Q2 2026 | — |
| Total new annualized premium sales (Aflac Japan) - yen | ¥19.6B | Q2 2026 | — |
| Total Recruited Agents | 2,526 | Q1 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AFL
this stock
Aflac Inc
|
$61.96B | +13.6% | -9.3% | 18.4 | 1.8% |
|
CILJF
China Life Insurance Co Ltd
|
$72.07B | -26.1% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$71.05B | +18.6% | — | — | 0.8% |
|
MET
Metlife Inc
|
$62.71B | +26.4% | +8.6% | 13.0 | 1.7% |
|
GWLIF
Great-West Lifeco Inc.
|
$58.79B | +33.2% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 5, 2026
- This year
- 19
Aflac Incorporated reported third-quarter net earnings of $303 million, or $.61 per diluted share, down from $1.6 billion, or $3.08 per diluted share, as $1.1 billion of net investment losses outweighed revenue declines.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AFL | -1.5% | +4.3% | +11.4% | +1.1% | +13.6% |
| SPY | -3.9% | -5.6% | -3.5% | -3.4% | +7.1% |
| vs SPY | +2.5% | +9.8% | +14.9% | +4.5% | +6.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.